Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Spike protein analysis from India's first SARS-CoV-2

A new study published on the preprint server bioRxiv analyzes viral spike protein sequences from the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak in West Bengal, India, comparing them with sequences from other Indian states and Wuhan, China.

30 Apr 2020

Identifying high-risk groups for COVID-19 in India

A new study from the Center for Disease Dynamics, Economics and Policy sets out indicators that identify the populations at the highest risk for COVID-19 in India. The study appears on the preprint website medRxiv in April 2020.

30 Apr 2020

New clinical trial to assess whether hypertension drug may reduce COVID-19 severity

Researchers at University of California San Diego School of Medicine have launched a clinical trial to investigate whether a drug approved for treating high blood pressure, heart failure and diabetic kidney disease might also reduce the severity of COVID-19 infections, lowering rates for intensive care unit admissions, the use of mechanical ventilators and all-cause mortality.

30 Apr 2020

COVID-19 pandemic will bring additional cancer deaths

With over 3.25 million people infected, healthcare systems of even the most developed nations are overwhelmed. Cancer patients and survivors, for example, are particularly vulnerable during this epidemic and not only because of their increased vulnerable immunocompromised state, which makes them prone to the infection. They are also at risk of missing out on essential cancer care due to the unavailability of resources.

30 Apr 2020

Pharmacy experts urge caution against use of antimalarial drugs to cure COVID-19

PHARMACY experts at the University of Huddersfield are urging caution over claims that widely-available antimalarial drugs could be a "magic bullet" to prevent and cure COVID-19. And the medicines can - if used rashly - have serious side effects.

30 Apr 2020

KHN’s ‘What the Health?’: SCOTUS decides an ACA case. No, not that case.

The Supreme Court this week rejected the efforts of a Republican-controlled Congress in 2014 to cut off funding to insurance companies under a provision of the Affordable Care Act.

30 Apr 2020

Scientists generate molecular models of compounds relevant for COVID-19

The discovery of suitable drugs that could help treat diseases is a long process. However, computer-aided drug design and simulation could speed up the process and also increase the possibilities say experts. This form of drug design and simulation could soon be the gold standard in drug development.

30 Apr 2020

New database catalogs peptides that may halt SARS-CoV-2 cell infection

In the quest for a highly specific and tailored treatment strategy against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a recent publication available on the preprint server bioRxiv describes a repository of designed peptides that interfere with the early stages of viral invasion process.

30 Apr 2020

Testing sewage could be useful in monitoring COVID-19 circulation in the population

Researchers in Italy have demonstrated the potential value of sewage system monitoring for studying trends in the circulation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).

30 Apr 2020

COVIDENCE UK study aims to identify highest risk factors for COVID-19

Scientists are calling on the public to sign up to a new study which will help identify who is most at risk of contracting COVID-19 and why some people become more ill than others with the disease.

30 Apr 2020

New Elsevier Coronavirus Research Hub offers free access to biomedical research tools, content

Elsevier, a global leader in information analytics specializing in science and health, is offering free access to a unique set of biomedical research tools and content to help researchers and life science companies accelerate efforts to address the current pandemic.

30 Apr 2020

ProteoGenix launches first Human Immune COVID-19 antibody library

ProteoGenix, a global leader in antibody production, is pleased to announce the first Human Immune COVID-19 library for the fast discovery of potent antibodies against SARS-CoV-2.

30 Apr 2020

UHB and Skin Analytics launch new skin cancer community assessment service

University Hospitals Birmingham NHS Foundation Trust and AI specialist Skin Analytics are to pilot a new skin cancer community assessment service to safely reduce delays in skin cancer detection and treatment during the Coronavirus pandemic.

30 Apr 2020

New mathematical model precisely estimates the death toll linked to COVID-19

A Rutgers engineer has created a mathematical model that accurately estimates the death toll linked to the COVID-19 pandemic in the United States and could be used around the world.

30 Apr 2020

Free clinics try to fill gaps as COVID sweeps away job-based insurance

The 55-year-old man, who moved to Tupelo from Georgia to take care of his dying father nearly four years ago, found manufacturing work that came with health insurance.

30 Apr 2020

Fear of coronavirus propels some smokers to quit

In 40 years of smoking, Katie Kennedy has tried four times to quit but always went back to cigarettes. Today, she is summoning a new mental image when a craving comes on: rows of COVID-19 patients hooked to ventilators.

30 Apr 2020

As coronavirus strikes, crucial data in electronic health records hard to harvest

When President Donald Trump started touting hydroxychloroquine as "one of the biggest game changers” for treating COVID-19, researchers hoped electronic health records could quickly tell them if he was on the right track.

30 Apr 2020

LabVantage Solutions announces new purpose-built Biobanking LIMS Accelerator for managing COVID-19 testing

LabVantage Solutions, Inc., the leading provider of laboratory informatics solutions and services including purpose-built LIMS that allow labs to go live faster and at a lower total cost, today announced the availability of its new purpose-built COVID-19 LIMS solution.

From LabVantage Solutions 30 Apr 2020

Newly launched clinical trial can help treat COVID-19 patients

Research by University of Iowa virologist Wendy Maury, PhD, has helped facilitate the launch of a new clinical trial in the United Kingdom of a drug that might help treat patients with COVID-19.

30 Apr 2020